Public company info - Ocumension Therapeutics , 01477.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ocumension Therapeutics, 01477.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12
Net Cash Flow from Operating Activities -200,243 -196,849 -212,574 -108,088 -43,350
Net Cash Flow from Return on Investments & Servicing of Finance 25,436 22,524 2,068 -63 20
　Interest Received 27,229 23,091 2,127 0 25
　Interest Paid -1,793 -567 -59 -63 -5
　Dividend Received 0 0 0 0 0
　Dividend Paid 0 0 0 0 0
　Others 0 0 0 0 0
Taxes (Paid) / Refunded -414 0 0 0 0
Net Cash Flow from Investing Activities 201,917 -1,368,381 627,569 -979,917 -66,685
　Additions to Fixed Assets -115,812 -195,370 -50,167 -766 -278
　Disposal of Fixed Assets 0 0 0 0 0
　Increase in Investments -179,990 -2,013,409 -1,343,702 -1,482,214 -102,874
　Decrease in Investments 181,243 1,955,622 1,832,083 1,061,608 36,707
　Net Cash Flow with Related Parties 0 0 0 -70,749 68,285
　Others 316,476 -1,115,224 189,355 -487,796 -68,525
Net Cash Flow before Financing Activities 26,696 -1,542,706 417,063 -1,088,068 -110,015
Net Cash Flow from Financing Activities -7,429 669,419 1,527,419 1,241,688 136,986
　New Loans 0 0 0 0 0
　Loans Repayment -9,147 -3,815 -1,382 -939 -46
　Fixed Income/Debt Instruments 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0
　Equity Financing 12,720 674,622 1,528,801 21 24
　Net Cash Flow with Related Parties 0 0 0 -70,749 68,285
　Others -11,002 -1,388 0 1,313,355 68,723
Increase(Decrease) in Cash & Cash Equivalents 19,267 -873,287 1,944,482 153,620 26,971
Cash & Cash Equivalents at Beginning of Year 1,125,221 2,034,319 192,404 25,629 0
Net Cash Flow due to Change in Exchange Rate/Others 25,561 -35,811 -102,567 13,155 -1,342
Cash & Cash Equivalents at End of Year 1,170,049 1,125,221 2,034,319 192,404 25,629
Currency Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved